New award for bevacizumab injections with pfizer, INC. Ordering period is august 13, 2025 to august 12, 2026 with four one-year options
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79725D0030
- Awardee
-
Pfizer Inc. UEI MHBQULRMEEJ5
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Bevacizumab Injection Pre-Solicitation · 36E79725R0019 · Posted Jan 28, 2025
- Last date to order 61% complete
- IDV ceiling
- $46,893,140.00
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Pfizer Inc. on August 13, 2025, with a ceiling of $46,893,140 for bevacizumab injections. The contract runs from August 13, 2025 through August 12, 2026, with four one-year option periods exercisable through August 12, 2027.
The solicitation sought bevacizumab products in multiple formulations—including Avastin, Mvasi, Alymsys, Vegzelma, and Zirabev—to support the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The procurement specified that offerors provide products under their own unique NDC number with their label as the only one affixed. Work is performed under NAICS 325412 (Pharmaceutical Preparation Manufacturing) in commercial item format.
The contract implements Executive Order 14398 regarding diversity, equity, and inclusion discrimination considerations. The contract was an unrestricted procurement with no set-aside category applied, issued as a single award based on the awardee's demonstrated capacity to provide uninterrupted supply of the specified bevacizumab injection products across five eligible variants and two package sizes (4mL and 16mL), with estimated annual usage ranging from approximately 4,800 to 23,500 vials depending on product type.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Add Subcontract Plan | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79725D0030?
36E79725D0030 was awarded to Pfizer Inc. by National Acquisition Center (Headquarters) on August 13, 2025.
How much is contract 36E79725D0030 worth?
36E79725D0030's own ceiling is $46,893,140.
Who can order from contract 36E79725D0030?
36E79725D0030 is a single award indefinite delivery contract.
Was contract 36E79725D0030 competed?
The extent of competition for 36E79725D0030 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV